Early Versus Delayed Invasive Management of Female Patients With Non–ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis
Circulation: Cardiovascular Interventions · 2025
DOI: 10.1161/circinterventions.124.014763 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Circulation: Cardiovascular Interventions, 2025. Verfasst von Gregory B Mills und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, United Kingdom (G.B.M., C.P.K., V.K.). Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Coronary Angiography, Time-to-Treatment, Non-ST Elevated Myocardial Infarction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Female patients are at greater risk of adverse events following non–ST-elevation acute coronary syndrome but less frequently receive guideline-recommended coronary angiography and revascularization. Routine invasive management benefits high-risk patients, but evidence informing the optimal timing of angiography specifically in female patients is lacking. METHODS: Medline, Web of Science, and Scopus were searched up to November 2023. Randomized controlled trials investigating early versus delayed timing of coronary angiography in patients with non–ST-elevation acute coronary syndrome were included. Individual patient data from female patients were extracted. The primary end point was a composite of all-cause mortality or myocardial infarction at 6 months. We performed a 1-stage individual patient data meta-analysis using random-effects Cox models. RESULTS: Six trials contributed individual patient data from 2257 female patients. Median time to coronary angiography was 5 hours in the early invasive group (n=1141) and 49 hours in the delayed invasive group (n=1116). Overall, there was no significant reduction in the risk of the primary end point in the early invasive group compared with the delayed group (hazard ratio, 0.79 [95% CI, 0.60–1.06]; P =0.12). Early invasive management was associated with a reduction in recurrent ischemia (hazard ratio, 0.60 [95% CI, 0.39–0.94]; P =0.025). In the prespecified subgroup analysis, high-risk female patients with Global Registry of Acute Coronary Events score >140 receiving early invasive management experienced a significantly reduced hazard for all-cause mortality or myocardial infarction at 6 months (hazard ratio, 0.65 [95% CI, 0.45–0.94]; P =0.021; P interaction =0.035). Similar benefits were observed for female patients with elevated cardiac biomarkers. CONCLUSIONS: Early invasive management in female patients with non–ST-elevation acute coronary syndrome, compared with delayed invasive management, was not associated with a significant reduction in the hazard for the primary end point. In prespecified subgroup analysis, high-risk female patients as assessed with Global Registry of Acute Coronary Events score >140 or elevated cardiac biomarkers experienced significant reductions in all-cause mortality or myocardial infarction at 6 months following early invasive management. REGISTRATION: URL: https://www.crd.york.ac.uk/prospero/ ; Unique identifier: CRD42023468604.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, United Kingdom (G.B.M., C.P.K., V.K.).
- Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom (G.B.M., C.P.K., V.K.).
- Population Health Research Institute, McMaster University and Hamilton Health Sciences, Ontario, Canada (S.M., D.T.).
- Department of Cardiology Research, Deventer Hospital, the Netherlands (E.A.B.).
- Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (T.E., D.H., L.H., L.K.).
- Department of Cardiology, Maastricht University Medical Center, the Netherlands (A.W.J.v.t.H.).
ORCID-Profile: Gregory B Mills, Shamir Mehta, Erik A Badings, Thomas Engstrøm, Arnoud W J van 't Hof, Dan Høfsten, Lars Køber, Aleksandra Milosevic, Goran Stankovic, Holger Thiele, Roxana Mehran, Vijay Kunadian
Zitieren
APA
Mills, G. B., Kotanidis, C. P., Mehta, S., Tiong, D., Badings, E. A., Engstrøm, T., van 't Hof, A. W. J., Høfsten, D., Holmvang, L., Jobs, A., Køber, L., Milasinovic, D., Milosevic, A., Stankovic, G., Thiele, H., Mehran, R., & Kunadian, V. (2025). Early Versus Delayed Invasive Management of Female Patients With Non–ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.124.014763
Vancouver
Mills GB, Kotanidis CP, Mehta S, Tiong D, Badings EA, Engstrøm T, et al. Early Versus Delayed Invasive Management of Female Patients With Non–ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis. Circulation: Cardiovascular Interventions. 2025. doi:10.1161/circinterventions.124.014763
BibTeX
@article{Mills2025,
author = {Mills, Gregory B and Kotanidis, Christos P and Mehta, Shamir and Tiong, Denise and Badings, Erik A and Engstrøm, Thomas and van 't Hof, Arnoud W J and Høfsten, Dan and Holmvang, Lene and Jobs, Alexander and Køber, Lars and Milasinovic, Dejan and Milosevic, Aleksandra and Stankovic, Goran and Thiele, Holger and Mehran, Roxana and Kunadian, Vijay},
title = {Early Versus Delayed Invasive Management of Female Patients With Non–ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis},
journal = {Circulation: Cardiovascular Interventions},
year = {2025},
doi = {10.1161/circinterventions.124.014763}
}
EUVIMED